Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 04 Mar 2022

Benefits of Targeted Molecular Therapy to Immune Infiltration and Immune-Related Genes Predicting Signature in Breast Cancer

in Cancer Immunity and Immunotherapy

Fahai Chen
Jianmin Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.824166

2,708 views
2 citations

Review

Published on 03 Mar 2022

Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?

in Cancer Immunity and Immunotherapy

Agnese Barnabei
Lidia Strigari
Andrea Corsello
Rosa Maria Paragliola
Luca Falzone
Roberto Salvatori
Salvatore Maria Corsello
Francesco Torino

Frontiers in Oncology

doi 10.3389/fonc.2022.798517

4,891 views
12 citations

Case Report

Published on 03 Mar 2022

Case Report: Complete Remission With Anti−PD−1 and Anti−VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma

in Cancer Immunity and Immunotherapy

Weiran Xu
Kai Wang
Wenguang Gu
Xinxin Nie
Hao Zhang
Chuanhao Tang
Li Lin
Jun Liang

Frontiers in Oncology

doi 10.3389/fonc.2022.809068

3,694 views
12 citations

Original Research

Published on 03 Mar 2022

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer

in Cancer Immunity and Immunotherapy

Zheng Zhu
Kun-Yu Teng
Jian Zhou
Yunyun Xu
Lifeng Zhang
Hua Zhao
Xueguang Zhang
Lei Tian
Zhiyao Li
Ting Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.814312

5,684 views
6 citations

Case Report

Published on 01 Mar 2022

Response of Tonsil Follicular Dendritic Cell Sarcoma to Multimodal Treatment Including Pembrolizumab: A Case Report and Literature Review

in Cancer Immunity and Immunotherapy

Nanxiang Chen
Wei Ba
Dawei Zhao
Lei Sheng
Xinxin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.816903

3,414 views
5 citations

Case Report

Published on 28 Feb 2022

Case Report: Opportunities and Challenges of Immunotherapy in Heavily-Treated EGFR-Mutant Advanced Squamous Cell Lung Carcinoma After Progression on EGFR-TKIs and Chemotherapy

in Cancer Immunity and Immunotherapy

Wei Jin
Xin Wang
Jie Wang
Lin Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.820408

2,488 views
1 citation

Original Research

Published on 28 Feb 2022

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker

in Cancer Immunity and Immunotherapy

Michael Berszin
Ioannis Michaelides
Julia Siemert
Louisa Röhl
Jana Wellhausen
Theresa Wald
Christopher Bohr
Julian Künzel
Tanja Gradistanac
Andreas Dietz

Frontiers in Oncology

doi 10.3389/fonc.2022.795277

3,749 views
7 citations

Systematic Review

Published on 25 Feb 2022

Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Yao Jin
Jiayan Wei
Yiming Weng
Jia Feng
Zexi Xu
Peiwei Wang
Xue Cui
Xinyi Chen
Jinsong Wang
Min Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.732814

5,416 views
9 citations

Systematic Review

Published on 24 Feb 2022

Evolution of Immunotherapy for Ovarian Cancer from a Bird’s-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics

in Cancer Immunity and Immunotherapy

Guangyi Jiang
Junjie Hong
Feng Shao
Qiang Wen
Feng Cheng
Tunan Yu
Jianqing Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.795129

5,413 views
7 citations

Systematic Review

Published on 24 Feb 2022

An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Chaoxing Liu
Huaijuan Guo
Haiyan Mao
Jiandong Tong
Mengxue Yang
Xuebing Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.753234

5,432 views
27 citations

Review

Published on 23 Feb 2022

When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies

in Cancer Immunity and Immunotherapy

Xiaofeng Dai
Jitian Li
Yiming Chen
Kostya (Ken) Ostrikov

Frontiers in Oncology

doi 10.3389/fonc.2022.837995

3,820 views
5 citations

Case Report

Published on 22 Feb 2022

Case Report: An “Immune-Cold” EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy

in Cancer Immunity and Immunotherapy

Qian Zhao
Xue Zhang
Qiang Ma
Nuo Luo
Zhulin Liu
Renyuan Wang
Yong He
Li Li

Frontiers in Oncology

doi 10.3389/fonc.2022.765997

3,401 views
5 citations

Review

Published on 17 Feb 2022

CD38: A Significant Regulator of Macrophage Function

in Cancer Immunity and Immunotherapy

Wentao Li
Yanling Li
Xi Jin
Qianjin Liao
Zhifang Chen
Honghua Peng
Yanhong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.775649

15,094 views
49 citations

Original Research

Published on 17 Feb 2022

Mesenchymal Stem Cells Inhibits Migration and Vasculogenic Mimicry in Nasopharyngeal Carcinoma Via Exosomal MiR-125a

in Cancer Immunity and Immunotherapy

Fangzhu Wan
Haojiong Zhang
Jiyi Hu
Li Chen
Shikai Geng
Lin Kong
Jiade J. Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.781979

3,601 views
8 citations

Case Report

Published on 17 Feb 2022

Case Report: Benefits of a NSCLC Patient With EGFR A289G/F287_G288insHA cis Mutations From Immunotherapy in Combination With Antiangiogenesis and Chemotherapy and Sequential Treatment of EGFR-TKI

in Cancer Immunity and Immunotherapy

He Zhang
Weiwei Dong
Huixia Zhao
Yanyan Hu
Xia You
Tingting Sun
Wenhua Xiao

Frontiers in Oncology

doi 10.3389/fonc.2022.826938

2,852 views
3 citations

Review

Published on 16 Feb 2022

Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy

in Cancer Immunity and Immunotherapy

Yuqing Zhou
Zhaoxia Liu
Tingtao Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.847350

9,493 views
20 citations